经皮椎间孔镜下微创治疗腰椎间盘突出症  

Percutaneous transforaminal endoscopic minimally invasive treatment for lumbar disc herniation

作　　者：童迅[1] 秦小虎[1] 孙凌梅[1] 吕客[1] 彭文娟[1] 宋一平[1] 

机构地区：[1]解放军第97医院疼痛康复科,江苏徐州221004

出　　处：《颈腰痛杂志》2015年第5期385-388,共4页The Journal of Cervicodynia and Lumbodynia

摘　　要：目的探讨经皮椎间孔镜下微创治疗腰椎间盘突出症的临床疗效。方法2012-10-2013-12对150例腰椎间盘突出症患者进行经皮椎间孔镜下微创治疗。疗效评定依据视觉模拟量表（Visual Analogue Scale，VAS），功能障碍指数（Oswestry Disability Index，ODI）和Maenab腰腿痛评定标准。结果随访3～18个月，平均6个月。下肢神经痛VAS评分术前（5．6±1．1）分，术后1周（2．0±0．5）分，术后3个月（0．7±0．3）分，手术前后结果差异有统计学意义（P〈0．05）；ODI评分术前（63．5±13．3）分，术后1周（20．4±5．4）分，术后3月（15．1±3．6）分，手术前后结果差异有统计学意义（P〈0．05）；Maenab腰腿痛评定标准结果为优109例，良27例，可12例，差2例，优良率90．7％。结论经皮椎间孔镜下微创治疗腰椎间盘突出症对脊柱稳定性破坏小，近期效果优良，是治疗腰椎间盘突出症的优选术式。Objective To evaluate the clinical efficacy of percutaneous transforaminal endo- scopic minimally invasive treatment for lumbar disc herniation. Methods From October 2012 to December 2013, 150 patients with lumbar disc herniation were treated with percutaneous transforaminal endoscopic minimally invasive treatment. The evaluation based on Visual Ana- logue Scale （VAS）, Oswestry Disability Index （ODI） and Macnab low back pain assessment standards. Results The average follow-up time was 6 months （ranged from 3 to 18 months）. Lower extremity neuropathic pain＇s VAS score decreased from（5.6±1.1） before surgery to（2.0±0.5） one week and （0.7±0.3）three months after surgery, the difference was statistically significant （P〈0.05）; ODI score decreased from （63.5±13.3）before surgery to （20.4±5.4） one week and （15.1±3.6） three months after surgery, the difference was statistically significant （P〈0.05）. Ac- cording to Macnab low back pain assessment standards, excellent in 109 cases, good in 27 cas- es, fair in 12 cases, the excellent and good rate was 90.7%. Conclusion Percutaneous trans- foraminal endoscopic treatment for lumbar disc herniation has small damage for spinal stability and good recent results. This technique is the preferred treatment of lumbar disc herniation sur- gical procedures.

关 键 词：腰椎间盘突出症 微创治疗 内窥镜 

分 类 号：R681.53[医药卫生—骨科学]